RESPIRATORY SYNCYTIAL VIRUS (RSV)

This study tests the RSV vaccine Arexvy in 170 adults with weakened immune systems to see if one or two doses work better. Participants will receive three vaccine doses over a year and be monitored for side effects and immune response. The goal is to find the best way to protect …

This study tests a new RSV vaccine in 25,000 adults aged 60 and older. The goal is to see if a single shot can prevent lower respiratory tract disease caused by RSV. Participants will be randomly assigned to receive either the vaccine or a placebo, and researchers will monitor sa…

This early-stage study tests the safety and immune response of experimental vaccines for respiratory syncytial virus (RSV) and a type of bird flu (H5N1) in 570 healthy adults aged 18 to 49. Participants will receive different vaccine formulas and be monitored for side effects and…

This study checks the safety of palivizumab, a medicine given as monthly shots to prevent severe RSV lung infections in infants under 2 years old who are at high risk. About 138 children will receive up to 5 injections, and researchers will monitor for side effects. The goal is t…

This study tests a new injection called SIBP-A16 in 140 healthy adults aged 18 to 45. The goal is to see if it is safe and how the body processes it, as a potential way to prevent respiratory syncytial virus (RSV) infection. Participants are randomly assigned to receive the study…

This study will test 10,000 people in Cambodia for antibodies against 57 different infectious diseases, including dengue, flu, and malaria. The goal is to learn how these diseases spread in communities and what factors increase risk. Results will help local health officials desig…